Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2005 1
2006 5
2007 2
2008 5
2009 6
2010 1
2011 2
2012 6
2013 13
2014 8
2015 11
2016 16
2017 19
2018 3
2019 3
2020 1
2021 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 23929770

85 results
Results by year
Filters applied: . Clear all
Page 1
Active vitamin D treatment for reduction of residual proteinuria: a systematic review.
de Borst MH, Hajhosseiny R, Tamez H, Wenger J, Thadhani R, Goldsmith DJ. de Borst MH, et al. J Am Soc Nephrol. 2013 Nov;24(11):1863-71. doi: 10.1681/ASN.2013030203. Epub 2013 Aug 8. J Am Soc Nephrol. 2013. PMID: 23929770 Free PMC article. Review.
Pentoxifylline plus ACEIs/ARBs for proteinuria and kidney function in chronic kidney disease: a meta-analysis.
Liu D, Wang LN, Li HX, Huang P, Qu LB, Chen FY. Liu D, et al. J Int Med Res. 2017 Apr;45(2):383-398. doi: 10.1177/0300060516663094. Epub 2017 Jan 1. J Int Med Res. 2017. PMID: 28415944 Free PMC article.
Vitamin D analogues to target residual proteinuria: potential impact on cardiorenal outcomes.
Humalda JK, Goldsmith DJ, Thadhani R, de Borst MH. Humalda JK, et al. Nephrol Dial Transplant. 2015 Dec;30(12):1988-94. doi: 10.1093/ndt/gfu404. Epub 2015 Jan 20. Nephrol Dial Transplant. 2015. PMID: 25609737 Free PMC article. Review.
Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis.
Currie G, Taylor AH, Fujita T, Ohtsu H, Lindhardt M, Rossing P, Boesby L, Edwards NC, Ferro CJ, Townend JN, van den Meiracker AH, Saklayen MG, Oveisi S, Jardine AG, Delles C, Preiss DJ, Mark PB. Currie G, et al. BMC Nephrol. 2016 Sep 8;17(1):127. doi: 10.1186/s12882-016-0337-0. BMC Nephrol. 2016. PMID: 27609359 Free PMC article. Review.
Normal 25-Hydroxyvitamin D Levels Are Associated with Less Proteinuria and Attenuate Renal Failure Progression in Children with CKD.
Shroff R, Aitkenhead H, Costa N, Trivelli A, Litwin M, Picca S, Anarat A, Sallay P, Ozaltin F, Zurowska A, Jankauskiene A, Montini G, Charbit M, Schaefer F, Wühl E; ESCAPE Trial Group. Shroff R, et al. J Am Soc Nephrol. 2016 Jan;27(1):314-22. doi: 10.1681/ASN.2014090947. Epub 2015 Jun 11. J Am Soc Nephrol. 2016. PMID: 26069294 Free PMC article.
Change in proteinuria after adding aldosterone blockers to ACE inhibitors or angiotensin receptor blockers in CKD: a systematic review.
Bomback AS, Kshirsagar AV, Amamoo MA, Klemmer PJ. Bomback AS, et al. Am J Kidney Dis. 2008 Feb;51(2):199-211. doi: 10.1053/j.ajkd.2007.10.040. Am J Kidney Dis. 2008. PMID: 18215698 Review.
Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical Trials.
Xie X, Liu Y, Perkovic V, Li X, Ninomiya T, Hou W, Zhao N, Liu L, Lv J, Zhang H, Wang H. Xie X, et al. Am J Kidney Dis. 2016 May;67(5):728-41. doi: 10.1053/j.ajkd.2015.10.011. Epub 2015 Nov 18. Am J Kidney Dis. 2016. PMID: 26597926
Fibroblast growth factor 23 and the antiproteinuric response to dietary sodium restriction during renin-angiotensin-aldosterone system blockade.
Humalda JK, Lambers Heerspink HJ, Kwakernaak AJ, Slagman MC, Waanders F, Vervloet MG, Ter Wee PM, Navis G, de Borst MH; NIGRAM Consortium. Humalda JK, et al. Am J Kidney Dis. 2015 Feb;65(2):259-66. doi: 10.1053/j.ajkd.2014.07.022. Epub 2014 Sep 30. Am J Kidney Dis. 2015. PMID: 25278093 Clinical Trial.
Efficacy and safety of combined vs. single renin-angiotensin-aldosterone system blockade in chronic kidney disease: a meta-analysis.
Susantitaphong P, Sewaralthahab K, Balk EM, Eiam-ong S, Madias NE, Jaber BL. Susantitaphong P, et al. Am J Hypertens. 2013 Mar;26(3):424-41. doi: 10.1093/ajh/hps038. Epub 2013 Jan 7. Am J Hypertens. 2013. PMID: 23382494 Free PMC article.
Effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on cardiovascular events and residual renal function in dialysis patients: a meta-analysis of randomised controlled trials.
Liu Y, Ma X, Zheng J, Jia J, Yan T. Liu Y, et al. BMC Nephrol. 2017 Jun 30;18(1):206. doi: 10.1186/s12882-017-0605-7. BMC Nephrol. 2017. PMID: 28666408 Free PMC article. Review.
85 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback